Top Buy Stocks: Glaxosmithkline Plc (GSK), Pfizer Inc (PFE), Rite Aid Corp (RAD), Seadrill Limited (SDRL), Symantec Corp. (SYMC)

NYSE: GSK (Glaxosmithkline Plc)

GlaxoSmithKline has announced it is opening a nonprofit cell research center called the Altius Institute for Biomedical Sciences to better understand how human genes function and use that research to accelerate the process of drug discovery.GSK has closed at $41.8, its traded Volume was 8898.42K shares, GSK opened the Day at $42.22, it made an intraday Low of $41.79, and an intraday High of $42.29. GSK’s close price is below its Short term MA, short term MA is below mid-term, and below long term MA. GSK (Glaxosmithkline Plc) 52-week High is $50.968, 52-week Low is: $40.131, it has supports at $41.18 and $34.26, resistances at $44.44 and $46.47. GSK’s earning is $6.59 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 6. Overall, this stock is rated BUY today.

NYSE: PFE (Pfizer Inc)

Pfizer’s Centers for Therapeutic Innovation and the Jeffrey Modell Foundation announced today a collaboration agreement to conduct research in the field of immunological diseases.

PFE has closed at $33.86, its traded Volume was 21878.2K shares, PFE opened the Day at $33.85, it made an intraday Low of $33.73, and an intraday High of $33.97. PFE’s close price is below its Short term MA, short term MA is below mid-term, and below long term MA. PFE (Pfizer Inc) 52-week High is $35.238, 52-week Low is: $26.813, it has supports at $33.08 and $27.52, resistances at $34.26 and $34.99. PFE’s earning is $1.44 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 24. Overall, this stock is rated BUY today.

NYSE: RAD (Rite Aid Corp)

Rite Aid Corp. said that for the four weeks ended June 27, 2015, same store sales increased 2.4 percent over the prior-year period.

RAD  has closed at $8.68, its traded Volume was 28384.5K shares, RAD opened the Day at $8.39, it made an intraday Low of $8.34, and an intraday High of $8.71. RAD’s close price is above its Short term MA, short term MA is above mid-term, and above long term MA. RAD (Rite Aid Corp) 52-week High is $9.07, 52-week Low is: $4.42, it has supports at $8.18 and $7.65, resistances at $9.06 and $10.58. RAD’s earning is $2.05 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 4. Overall, this stock is rated BUY today.

NYSE: SDRL (Seadrill Limited)

Seadrill Limited has entered into a new forward agreement for 4,091,425 Sevan Drilling Limited shares expiring August 6, 2015 with a strike price of NOK 12.486.

SDRL has closed at $9.74, its traded Volume was 10492.4K shares, SDRL opened the Day at $9.71, it made an intraday Low of $9.7, and an intraday High of $9.89. SDRL’s close price is below its Short term MA, short term MA is below mid-term, and below long term MA. SDRL (Seadrill Limited) 52-week High is $37.855, 52-week Low is: $8.58, it has supports at $8.97 and $7.46, resistances at $12.96 and $15.43. SDRL’s earning is $2.76 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 4. Overall, this stock is rated BUY today.

NASDAQ: SYMC (Symantec Corp)

Symantec Corporation is looking for potential buyers for its Veritas business and according to Bloomberg, the company will be selling the business to The Carlyle Group LP, a private equity firm, for $7 billion to $8 billion.

SYMC  has closed at $22.99, its traded Volume was 5458.83K shares, SYMC opened the Day at $22.92, it made an intraday Low of $22.78, and an intraday High of $23.19. SYMC’s close price is below its Short term MA, short term MA is below mid-term, and below long term MA. SYMC (Symantec Corp) 52-week High is $26.989, 52-week Low is: $21.271, it has supports at $22.26 and $18.52, resistances at $24.56 and $25.99. SYMC’s earning is $1.26 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 18. Overall, this stock is rated BUY today.


Posted

in

by

Tags:

Comments

Leave a Reply